MMIT is a company operating in the Business Services sector, specifically within the Information Technology and Services domain. Founded in 1994 and based in the United States, MMIT employs between 201 and 500 individuals and reported a revenue of approximately $112 million. The company specializes in market access strategies for pharmaceutical products, as evidenced by its published document, "The Essentials of Market Access." This eBook outlines critical aspects of developing commercialization strategies for pharmacy benefit therapies, emphasizing the importance of early planning for market access, ideally 12 to 18 months prior to FDA approval. It discusses the roles of various stakeholders in access decisions, formulary exceptions, and the impact of prior authorization restrictions on medication prescribing. MMIT's content indicates a focus on providing guidance for pharmaceutical companies to enhance their commercialization efforts and navigate the complexities of market access effectively. The company appears committed to supporting clients in optimizing their market strategies to improve product launch outcomes.